Yumiko Matsuo
Direktor/Vorstandsmitglied bei TRANSACTION CO.,LTD.
Profil
Yumiko Matsuo is an Independent Outside Director at Transaction Co., Ltd.
and an Outside Director at Triumfield Holdings Co., Ltd.
She was an Outside Director at SB-Kawasumi Laboratories, Inc. and an Independent Director at SDS Biotech KK from 2016 to 2021.
Aktive Positionen von Yumiko Matsuo
| Unternehmen | Position | Beginn |
|---|---|---|
| TRANSACTION CO.,LTD. | Direktor/Vorstandsmitglied | 27.11.2020 |
| Triumfield Holdings Co., Ltd. | Direktor/Vorstandsmitglied | 01.12.2018 |
Ehemalige bekannte Positionen von Yumiko Matsuo
| Unternehmen | Position | Ende |
|---|---|---|
| SDS BIOTECH K.K. | Direktor/Vorstandsmitglied | 02.08.2021 |
| KAWASUMI LABORATORIES, INCORPORATED | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TRANSACTION CO.,LTD. | Process Industries |
| Private Unternehmen | 3 |
|---|---|
SDS Biotech KK
 SDS Biotech KK Chemicals: AgriculturalProcess Industries SDS Biotech KK engages in the manufacturing of agricultural chemicals. It imports and markets pesticides and other agro-chemical products such as industrial fungicides, disinfectants and specialty chemicals. The company was founded on October 7, 1968 and is headquartered in Tokyo, Japan. | Process Industries |
SB-Kawasumi Laboratories, Inc.
 SB-Kawasumi Laboratories, Inc. Medical SpecialtiesHealth Technology Kawasumi Laboratories, Inc. engages in the manufacture and sale of medical devices and pharmaceuticals. It operates through the Hemodialysis and Plasmapheresis; and Blood Transfusion and Endovascular segments. The Hemodialysis and Plasmapheresis segment develops, produces, and sells dialyzers, blood tubing lines, arteriovenous fistula needles, and isotonic sodium chloride solutions. It also offers removal of pathogenic factors from blood by extracorporeal circulation. The Blood Transfusion and Endovascular segment offers infusion therapy products, blood bags, apheresis kits, and intravenous sets. The company was founded by Takumi Kawano on December 1, 1954 and is headquartered in Tokyo, Japan. | Health Technology |
| Triumfield Holdings Co., Ltd. |
